Search research articles
Contact Us
Filters
Showing results (621-630 of 634) with videos related to
Page
of 64
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 16, 2013
Bladder cancer
Peter E Clark, Neeraj Agarwal, Matthew C Biagioli, et al.
The Journal of Urology
|
September 16, 2025
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer
Sam S Chang, Karim Chamie, Eugene Kramolowsky, et al.
Nature Medicine
|
November 9, 2024
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial
Roger Li, Nancy Y Villa, Xiaoqing Yu, et al.
The Journal of Urology
|
July 6, 2026
Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary Disease
Sam S Chang, Karim Chamie, Charles A Seabury, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 13, 2017
Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation
Arthur W Baker, Sarah S Lewis, Barbara D Alexander, et al.
European Urology Oncology
|
October 2, 2020
Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria
Franciscus Johannes P van Valenberg, Andrew M Hiar, Ellen Wallace, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024
Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2017
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
Philippe E Spiess, Neeraj Agarwal, Rick Bangs, et al.
Page
of 64
Search research articles
Search
Showing results (621-630 of 634) with videos related to
Sort By:
Page
of 64
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 16, 2013
Bladder cancer
Peter E Clark, Neeraj Agarwal, Matthew C Biagioli, et al.
The Journal of Urology
|
September 16, 2025
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer
Sam S Chang, Karim Chamie, Eugene Kramolowsky, et al.
Nature Medicine
|
November 9, 2024
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial
Roger Li, Nancy Y Villa, Xiaoqing Yu, et al.
The Journal of Urology
|
July 6, 2026
Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary Disease
Sam S Chang, Karim Chamie, Charles A Seabury, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 13, 2017
Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation
Arthur W Baker, Sarah S Lewis, Barbara D Alexander, et al.
European Urology Oncology
|
October 2, 2020
Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria
Franciscus Johannes P van Valenberg, Andrew M Hiar, Ellen Wallace, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024
Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2017
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
Philippe E Spiess, Neeraj Agarwal, Rick Bangs, et al.
Page
of 64